Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

Total article views   HTML views PDF downloads Totals
7,412 Dovepress* 6,566+ 662 7,228
PubMed Central* 846 267 1,113
Totals 7,412 929 8,341
*Since 3 December 2020

View citations on PubMed Central and Google Scholar